What Is The Current and Historic Market Size Analysis Of The Enteric Disease Testing Market?
The enteric disease testing market has seen considerable growth due to a variety of factors.
• In recent times, there has been significant growth in the size of the enteric disease testing market. It is anticipated to escalate from $4.62 billion in 2024 to $4.87 billion in 2025, displaying a compound annual growth rate (CAGR) of 5.4%.
The notable growth observed during the historical period is mostly due to factors including food and water safety issues, rise in outbreaks and epidemics, globalized food procurement, increase in travel-related infections, and regulatory standards.
What Are The Predictions for The Enteric Disease Testing Market Size In The Coming Years?
The enteric disease testing market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market for enteric disease testing is projected to experience significant growth, reaching a valuation of $6.29 billion by 2029, representing a compound annual growth rate (CAGR) of 6.6%.
Factors contributing to this anticipated growth during the forecast period are the incorporation of telemedicine and remote monitoring, the impacts of climate change, cross-sector collaboration, antimicrobial resistance, and the emergence of new enteric pathogens. Key trends predicted to shape the market within the forecast period include the introduction of molecular diagnostics, the integration of digital health technology, artificial intelligence and machine learning, the adoption of syndromic testing, and point-of-care testing.
What Are The Essential Drivers Behind The Growth Of The Enteric Disease Testing Market?
The rise in instances of diarrhea and hemolytic urea syndrome (HUS) is projected to spur the expansion of the enteric disease testing market in the future. Diarrhea disorders are primarily prompted by the ingestion of infected food and water. HUS, a malady affecting blood and blood vessels, is predominantly seen in children suffering from diarrhea. Diarrheal diseases and HUS are among the main reasons for mortality in children below five years of age. The growing frequency of diarrhea and hemolytic necessitates testing solutions, thereby escalating the necessity for enteric disease testing solutions. As an example, the Centers for Disease Control and Prevention state that diarrhea is the second highest cause of death in children under 5, noting 801 thousand cases globally, contributing to one in every nine child deaths annually. Consequently, the escalating incidences of enteric ailments will stimulate the expansion of the enteric disease testing market.
How Is The Global Enteric Disease Testing Market Divided Into Key Segments?
The enteric disease testing market covered in this report is segmented –
1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Other Disease Types
2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography And Spectrometry, Other Technologies
3) By Application: Hospitals, Research Centers, Clinics, Other Applications
Subsegments:
1) By Bacterial Enteric Disease: Salmonella, Escherichia coli (E. coli), Shigella, Campylobacter, Clostridium Difficile (C. diff)
2) By Parasitic Enteric Disease: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella spiralis
3) By Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus
4) By Other Disease Types: Fungal Enteric Infections, Foodborne Illnesses, Antibiotic-Associated Diarrhea
Pre-Book The Enteric Disease Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Insights Market?
Major enterprises in the enteric disease testing market are investing in the creation of sophisticated diagnostic tools such as laboratory equipment to increase accuracy in diagnostics and better patient results. Laboratory equipment are critical tools used in scientific and medical labs to perform experiments, scrutinize specimens and produce precise data for diagnosis. They are crucial in improving the accuracy of diagnostic procedures and enabling research in several areas, including enteric disease testing. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co., Ltd., a biotechnology firm from China, introduced real-time PCR kits designed specifically for diagnosing gastrointestinal infections. These kits boast high sensitivity and specificity, allowing for precise detection of negligible levels of nucleic acids in various specimens. They also facilitate swift analysis, drastically cutting down on processing time and enhancing throughput in diagnostic and research practices.
Who Are the Key Players in the Enteric Disease Testing Market?
Major companies operating in the enteric disease testing market include:
• Becton Dickinson and Company
• Biomerica Inc.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• Cepheid Inc.
• Coris Bioconcept
• DiaSorin Molecular LLC
• MMeridian Life Science Inc.
• Trinity Biotech plc.
• Abbott Laboratories
• Fisher Scientific Inc.
• Alere Inc.
• 3M Company.
• Asure Quality
• Bureau Veritas
• Meridian Bioscience Inc.
• Hologic Inc.
• Luminex Corporation
• Nanosphere Inc.
• Quidel Corporation
• Roche Diagnostics
• Siemens Healthcare Diagnostics Inc.
• Vela Diagnostics
• GenMark Diagnostics
• BioFire Diagnostics LLC
• Veredus Laboratories Pte Ltd.
What are the Regional Insights into the Enteric Disease Testing Market?
North America was the largest region in the enteric disease testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
